A grouping of pharmaceutical companies will lobby for a review of a Health Ministry regulation that revokes the right of some of its members to register, and thus sell, drugs they import.The regulation, issued last Monday, applies in particular to PBFs -- a corporate classification set by the...

Friday, 07 November, 2008 | 14:34 WIBTEMPO Interactive, Jakarta:The inclusion of the pharmaceutical industry in the negative investment list will hamper its expansion. The policy is seen to be affecting future foreign investment in Indonesia.